Subscribe for free
Cancerworld
Facebook Twitter LinkedIn

About the Magazine

  • About us
  • Editorial Team
  • Events
  • Archive
  • Contacts

Articles

  • Policy
  • Practice Points
  • Delivery of Care
  • Biology basic
  • Medicine
  • Featured

Contents

  • News
  • Editorials
  • Interviews to the Expert
  • In the Hot Seat
  • Profiles
  • Obituaries
  • Voices

ESO College Corner

  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner

Gut microbiome offers new avenue for detecting colorectal cancer
News

Gut microbiome offers new avenue for detecting colorectal cancer

Significant variations in the gut microbiome can be identified between people who develop pre-cancerous colonic lesions and those who do not. The Dutch study, abstract OP118, presented at United European Gastroenterology (UEG)…

By Janet Fricker | Nov 2, 2023
Machine learning improves accuracy of survival prediction
News

Machine learning improves accuracy of survival prediction

An artificial intelligence prototype has been developed to estimate the survival of newly diagnosed cancer patients with breast, thyroid, and pancreatic cancers. The study, abstract 4160, presented at the American College of…

By Janet Fricker | Nov 2, 2023
Walkable neighbourhoods lower risk of obesity related cancers
News

Walkable neighbourhoods lower risk of obesity related cancers

Women living in US neighbourhoods with higher levels of ‘walkability’ have lower risks of obesity related cancers, including postmenopausal breast, endometrial, ovarian, and multiple myeloma. The prospective study, published in Environmental Health…

By Janet Fricker | Oct 20, 2023
Dichloroacetate shows promise in treating cancer-related fatigue
News

Dichloroacetate shows promise in treating cancer-related fatigue

Dichloroacetate, a drug targeting the metabolism, helped alleviate cancer related fatigue in mouse models of melanoma and colon cancer, reports a study published in the American Journal of Physiology Endocrinology and Metabolism, 2…

By Janet Fricker | Oct 19, 2023
Combination immunotherapy with novel immune-oncology agents benefit NSCLC patients in presurgical setting
News

Combination immunotherapy with novel immune-oncology agents benefit NSCLC patients in presurgical setting

Patients with resectable non-small-cell lung cancer show improved major pathological response rates with combination immune oncology agents versus single-agent immunotherapy. The NeoCOAST trial, published in Cancer Discovery, 14 September, demonstrated that combining…

By Janet Fricker | Oct 6, 2023
Trial defines breast cancer population who can omit sentinel node biopsy
News

Trial defines breast cancer population who can omit sentinel node biopsy

Breast cancer patients with no axillary lymph node involvement apparent on ultrasound scans, and with tumours less than 2cm, had similar outcomes regardless of whether they underwent sentinel lymph node biopsy or…

By Janet Fricker | Oct 6, 2023
Statin use lowers risk of colorectal cancer in inflammatory bowel disease
News

Statin use lowers risk of colorectal cancer in inflammatory bowel disease

Statin use was associated with a lower risk of colorectal cancer, colorectal cancer related mortality, and all-cause mortality in a patient population with inflammatory bowel disease. The Swedish study, published online in…

By Janet Fricker | Sep 22, 2023
New drug breaks through fibrotic tissue in pancreatic cancer
News

New drug breaks through fibrotic tissue in pancreatic cancer

A drug targeting scar-like ‘fibrotic’ tissue within tumours shows promise for treating pancreatic ductal adenocarcinoma (PDAC). In the study, reported online in Nature Cancer, 28 August, Australian investigators showed in mouse and…

By Janet Fricker | Sep 21, 2023
Anti-oestrogen provides novel strategy to boost checkpoint inhibitors
News

Anti-oestrogen provides novel strategy to boost checkpoint inhibitors

Adding anti-oestrogen therapy improves response to combined chemotherapy and immune checkpoint inhibition in tumours that do not express oestrogen receptors. The Japanese study, published in British Journal of Cancer, provides a new…

By Janet Fricker | Sep 8, 2023
Anticancer benefits from Mediterranean ‘lifestyle’ can be transferred to non-Mediterranean population
News

Anticancer benefits from Mediterranean ‘lifestyle’ can be transferred to non-Mediterranean population

High adherence to a ‘Mediterranean lifestyle’ is associated with lower cancer mortality in a dose-responsive manner. The study, published in Mayo Clinic Proceedings (16 August), showed that UK adults who are the…

By Janet Fricker | Sep 8, 2023
    « 1 … 7 8 9 10 11 … 24 »

Subscribe free to Cancerworld

Fortnightly features, news and analysis — straight to your inbox.

Subscribe Now

About the Magazine

  • About us
  • Editorial Team
  • Events
  • Archive
  • Contacts
  • ESO College Corner

Articles

  • Policy
  • Practice Points
  • Delivery of Care
  • Biology basic
  • Medicine
  • Featured

Contents

  • News
  • Editorials
  • Interviews to the Expert
  • In the Hot Seat
  • Profiles
  • Obituaries
  • Voices
Cancerworld
About us Articles Media Corner Privacy Policy Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.)  |  Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States  |  [email protected]